Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.48 |
| ▸ | CA1 | P00915 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 5/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL500730 | 1.00 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| SCHEMBL260648 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| Potassium Ion SCHEMBL472611 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| Lithium Ion SCHEMBL472702 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| SCHEMBL4603618 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| SCHEMBL500878 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| SCHEMBL4604488 | 0.96 | CA12 (0.48) | CA12CA1CA2CA9CA14 | |
| SCHEMBL9556912 | 0.93 | CA12 (0.46) | CA12CA1CA2CA9CA14 | |
| SCHEMBL4655372 | 0.90 | KDM4E (0.43) | CA12CA1CA2CA9CA14 | |
| SCHEMBL6394369 | 0.84 | TSHR (0.47) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9593229-B2 | Polylactic acid resin composition and resin molded article thereof | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2017-03-14 | — | — | US | claimed |
| EP-3029108-B1 | POLYLACTIC ACID RESIN COMPOSITION | KAO CORP (JP) | 2020-04-22 | — | — | EP | disclosed |
| US-10100191-B2 | Polylactic acid resin composition | KAO CORPORATION (JP) | 2018-10-16 | — | — | US | disclosed |
| EP-2933294-B9 | POLYLACTIC ACID RESIN COMPOSITION AND RESIN MOLDED ARTICLE THEREOF | DAI-ICHI KOGYO SEIYAKU CO LTD (JP) | 2017-08-16 | — | — | EP | disclosed |
| EP-2933294-B1 | POLYLACTIC ACID RESIN COMPOSITION AND RESIN MOLDED ARTICLE THEREOF | DAI-ICHI KOGYO SEIYAKU CO LTD (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-9593229-B2 | Polylactic acid resin composition and resin molded article thereof | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20160168375-A1 | POLYLACTIC ACID RESIN COMPOSITION | KAO CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| EP-3029108-A1 | POLYLACTIC ACID RESIN COMPOSITION | Kao Corporation (JP) | 2016-06-08 | — | — | EP | disclosed |
| EP-2933294-A1 | POLYLACTIC ACID RESIN COMPOSITION AND RESIN MOLDED ARTICLE THEREOF | Dai-Ichi Kogyo Seiyaku Co., Ltd. (JP) | 2015-10-21 | — | — | EP | disclosed |
| US-9139710-B2 | Aliphatic polyester resin compositions, molded articles of aliphatic polyester resin and method of producing same | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 2015-09-22 | — | — | US | disclosed |
| US-8785520-B2 | Process for production of polylactic acid resin composition | KAO CORPORATION (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20140171559-A1 | POLYLACTIC ACID RESIN COMPOSITION AND RESIN MOLDED ARTICLE THEREOF | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2014-06-19 | — | — | US | disclosed |
| EP-2532711-A1 | PROCESS FOR PRODUCTION OF POLYLACTIC ACID RESIN COMPOSITION | Kao Corporation (JP) | 2012-12-12 | — | — | EP | disclosed |
| US-20120296017-A1 | PROCESS FOR PRODUCTION OF POLYLACTIC ACID RESIN COMPOSITION | KAO CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20100292381-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED BODY OBTAINED BY MOLDING THE SAME | UNITIKA LTD. (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-1707598-B1 | ALIPHATIC POLYESTER RESIN COMPOSITION, ALIPHATIC POLYESTER RESIN MOLDING AND PROCESS FOR PRODUCING THE ALIPHATIC POLYESTER RESIN MOLDING | TAKEMOTO OIL & FAT CO LTD (JP) | 2008-07-09 | — | — | EP | disclosed |
| US-20070270535-A1 | Aliphatic Polyester Resin Compositions, Molded Articles of Aliphatic Polyester Resin and Method of Producing Same | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 2007-11-22 | — | — | US | disclosed |
| EP-1707598-A1 | ALIPHATIC POLYESTER RESIN COMPOSITION, ALIPHATIC POLYESTER RESIN MOLDING AND PROCESS FOR PRODUCING THE ALIPHATIC POLYESTER RESIN MOLDING | Takemoto Yushi Kabushiki Kaisha (JP) | 2006-10-04 | — | — | EP | disclosed |
| US-6830859-B2 | Electrostatic latent images; containing barium salt of sulfoisophthalic acid | RICOH COMPANY, LTD. (JP) | 2004-12-14 | — | — | US | disclosed |
| US-20030077534-A1 | Charge control agent and toner using same | RICOH COMPANY, LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030077534-A1 | Charge control agent and toner using same | BET1, SMARCA5, SMARCA1 | CA12 54/4885CA1 58/4885CA2 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.